Pathway analysis of the RNAseq dataset provided a useful insight of what may be triggering the ILC2 response, and identification of IL-2 and other novel upstream regulatory pathways could also provide useful mechanisms to modify ILC2 behavior during the acute phase of MI. This evidence concerns the gene IL2 and myocardial infarction.